Diabordo, Jeralyn D.
HRN: 29-24-13 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/26/2026
CEFUROXIME 750MG (VIAL)
06/26/2026
07/03/2026
IV
750mg
Q8
UTI
Checking Initial Appropriateness